The study of E-cadherine and CD44 immunoexpression in oral squamous cell carcinoma

Romanian Journal of Morphology and Embryology

Volumn 49, Issue 2, 2008, Pages 189-193

  Simionescu, Cristiana ^a   Margaritescu C L ^a   Surpateanu M ^a   Mogoanta L ^a   Zǎvoi, Roxana ^a   Ciurea, Raluca ^a   Şurlin, Petra ^a   Stepan, A ^a  

^a UNIVERSITY OF MEDICINE AND PHARMACY OF CRAIOVA   (Romania)

Author keywords

CD44; E cadherine; Oral squamous cell carcinoma

Indexed keywords

CADHERIN; CD44 PROTEIN, HUMAN; HERMES ANTIGEN; TUMOR MARKER;

ARTICLE; CELL DIFFERENTIATION; DISEASE COURSE; HUMAN; IMMUNOHISTOCHEMISTRY; METABOLISM; MOUTH TUMOR; PROGNOSIS; SQUAMOUS CELL CARCINOMA;

ANTIGENS, CD44; CADHERINS; CARCINOMA, SQUAMOUS CELL; CELL DIFFERENTIATION; DISEASE PROGRESSION; HUMANS; IMMUNOHISTOCHEMISTRY; MOUTH NEOPLASMS; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 52749099258     PISSN: 12200522     EISSN: 20668279     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. SILVERMAN S. JR., Demographics and occurrence of oraland pharyngeal cancers. The outcomes, the trends, thechallenge, J Am Dent Assoc, 2001, 132 Suppl:7S-11S.
2. LANDIS S. H., MURRAY T., BOLDEN S., WINGO P. A., Cancerstatistics, 1999, CA Cancer J Clin, 1999, 49(1):8-31.
3. RIES L. A. G., HANKEY B. F., MILLER B. A., HARTMAN A. M., EDWARDS B. K., Cancer Statistics Review, 1973-1988, National Cancer Institute, NIH Publication No. 91-2789, Bethesda, 1991.
4. MITHANI S. K., MYDLARZ W. K., GRUMBINE F. L., SMITH I. M., CALIFANO J. A., Molecular genetics of premalignant orallesions, Oral Dis, 2007, 13(2):126-133.
5. MEHROTRA R., GUPTA A., SINGH M., IBRAHIM R., Applicationof cytology and molecular biology in diagnosingpremalignant or malignant oral lesions, Mol Cancer, 2006, 5:11.
6. MASSARELLI E., BROWN E., TRAN N. K., LIU D. D., IZZO J. G., LEE J. J., El-Naggar A. K., HONG W. K., PAPADIMITRAKOPOULOU V. A., Loss of E-cadherin and p27 expression is associated with head and neck squamous tumorigenesis, Cancer, 2005, 103(5):952-959.
7. Santos-García A., Abad-Hernández M. M., Fonseca-Sánchez E., Julián-González R., Galindo-Villardón P., Cruz-Hernández J. J., Bullón-Sopelana A., E-cadherin, laminin and collagen IV expression in the evolution from dysplasia to oral squamous cell carcinoma, Med Oral Patol Oral Cir Bucal, 2006, 11(2):E100-E105.
8. LIN Y. C., WU M. Y., LI D. R., WU X. Y., ZHENG R. M., Prognostic and clinicopathological features ofE-cadherin, alpha-catenin, beta-catenin, gamma-catenin and cyclin D1 expression in human esophageal squamous cell carcinoma, World J Gastroenterol, 2004, 10(22):3235-3239.
9. PYO S. W., HASHIMOTO M., KIM Y. S., KIM C. H., LEE S. H., JOHNSON K. R., WHEELOCK M. J., PARK J. U., Expression ofE-cadherin, P-cadherin and N-cadherin in oral squamous cell carcinoma: correlation with the clinicopathologic features and patient outcome, J Craniomaxillofac Surg, 2007, 35(1):1-9.
10. HUNG K. F., CHANG C. S., LIU C. J., LUI M. T., CHENG C. Y., KAO S. Y., Differential expression of E-cadherin inmetastatic lesions comparing to primary oral squamous cell carcinoma, J Oral Pathol Med, 2006, 35(10):589-594.
11. ZHONG L. P., LI J., ZHANG C. P., ZHU H. G., SUN J., ZHANG Z. Y., Expression of E-cadherin in cervical lymph nodes from primary oral squamous cell carcinoma patients, Arch Oral Biol, 2007, 52(8):740-747.
12. MAHOMED F., ALTINI M., MEER S., Altered E-cadherin/beta- catenin expression in oral squamous carcinoma with andwithout nodal metastasis, Oral Dis, 2007, 13(4):386-392.
13. SAKAKI T., WATO M., KAJI R., MUSHIMOTO K., SHIRASU R., TANAKA A., Correlation of E- and P-cadherin expression with differentiation grade and mode of invasion in gingival carcinoma, Pathol Int, 1994, 44(4):280-286.
14. KANKE M., FUJII M., KAMEYAMA K., KANZAKI J., TOKUMARU Y., IMANISHI Y., TOMITA T., MATSUMURA Y., Role of CD44 variantexon 6 in invasion of head and neck squamous cell carcinoma, Arch Otolaryngol Head Neck Surg, 2000, 126(10):1217-1223.
15. González-Moles M. A., BRAVO M., Ruiz-Avila I., ESTEBAN F., Bascones-Martínez A., González-Moles S., Adhesion molecule CD44 expression in non-tumour epithelium adjacent to tongue cancer, Oral Oncol, 2004, 40(3):281-286.
16. BÁNKFALVI A., KRASSORT M., BUCHWALOW I. B., VÉGH A., FELSZEGHY E., PIFFKÓ J., Gains and losses of adhesionmolecules (CD44, E-cadherin, and beta-catenin) during oral carcinogenesis and tumour progression, J Pathol, 2002, 198(3):343-351.
17. CARINCI F., STABELLINI G., CALVITTI M., PELUCCHI S., TARGA L., FARINA A., PEZZETTI F., PASTORE A., CD44 asprognostic factor in oral and oropharyngeal squamous cell carcinoma, J Craniofac Surg, 2002, 13(1):85-89.
18. SATO S., MIYAUCHI M., KATO M., KITAJIMA S., KITAGAWA S., HIRAOKA M., KUDO Y., OGAWA I., TAKATA T., Upregulated CD44v9 expression inhibits the invasion of oral squamous cell carcinoma cells, Pathobiology, 2004, 71(4):171-175.
19. FONSECA I., PEREIRA T., Rosa-Santos J., SOARES J., Expression of CD44 isoforms in squamous cell carcinoma of the border of the tongue: A correlation with histological grade, pattern of stromal invasion, and cell differentiation, J Surg Oncol, 2001, 76(2):115-120.